Inflammatory Status is a clinical measure of the level of chronic, low-grade systemic inflammation present in the body, typically assessed by quantifying specific circulating biomarkers like high-sensitivity C-reactive protein (hs-CRP) and various cytokines. Elevated inflammatory status is a significant underlying factor in metabolic dysfunction, hormonal imbalance, and the progression of age-related diseases. Managing this status is central to preventative health and optimizing systemic resilience.
Origin
The term originates from clinical immunology and pathology, recognizing that inflammation is not only an acute response to injury but also a chronic, subclinical condition. The “status” component implies a measurable, persistent state of immune activation. It is a critical diagnostic indicator in the hormonal and metabolic health space, often linked to visceral fat and insulin resistance.
Mechanism
Chronic inflammation is often driven by dysfunctional adipose tissue, particularly visceral fat, which releases pro-inflammatory adipokines and cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). These signaling molecules interfere with insulin receptor signaling, leading to peripheral insulin resistance. Furthermore, they can disrupt the hypothalamic-pituitary axes, negatively affecting the secretion and function of key regulatory hormones like cortisol and testosterone.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.